NUCLEIX

nucleix-logo

Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation patterns. Nucleix offers a urine test for monitoring of bladder cancer called Bladder EpiCheck and a blood test for early detection of lung cancer called Lung EpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel.

#SimilarOrganizations #People #Financial #Website #More

NUCLEIX

Industry:
Biotechnology Health Care Information Technology Manufacturing Medical Device Personal Health

Founded:
2008-01-01

Address:
Rehovot, HaMerkaz, Israel

Country:
Israel

Website Url:
http://www.nucleix.com

Total Employee:
11+

Status:
Active

Contact:
+97289161616

Email Addresses:
[email protected]

Total Funding:
82.99 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Apache


Similar Organizations

angeion-corporation-logo

Angeion Corporation

Angeion Corp develops, manufactures and markets non-invasive cardiorespiratory diagnostic systems.

crossway-logo

CROSSWAY

CROSSWAY develops and manufactures physical fitness diagnostic systems and measuring devices.

ewave-logo

eWAVE

eWAVE develops, manufactures, and markets optical transport systems.

norman-biological-technology-logo

Norman Biological Technology

Norman Biological Technology is a manufacturer of automated chemiluminescence system.


Current Advisors List

dan-j-gelvan_image

Dan J. Gelvan Member of Board of Directors @ Nucleix
Board_member

Current Employees Featured

adam-wasserstrom_image

Adam Wasserstrom
Adam Wasserstrom Co-founder, VP Software & Analytics @ Nucleix
Co-founder, VP Software & Analytics
2008-07-01

danny-frumkin_image

Danny Frumkin
Danny Frumkin VP Research & Co-founder @ Nucleix
VP Research & Co-founder

chris-hibberd_image

Chris Hibberd
Chris Hibberd Chief Executive Officer @ Nucleix
Chief Executive Officer
2020-01-01

w-todd-myers_image

W. Todd Myers
W. Todd Myers Chief Financial Officer @ Nucleix
Chief Financial Officer
2019-08-01

chris-hibberd_image

Chris Hibberd
Chris Hibberd Executive Chairman @ Nucleix
Executive Chairman
2019-08-01

Founder


adam-wasserstrom_image

Adam Wasserstrom

danny-frumkin_image

Danny Frumkin

elon-ganor_image

Elon Ganor

Investors List

zohar-zisapel_image

Zohar Zisapel

Zohar Zisapel investment in Venture Round - Nucleix

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Venture Round - Nucleix

sands-capital-ventures_image

Sands Capital Ventures

Sands Capital Ventures investment in Venture Round - Nucleix

orbimed-advisors_image

OrbiMed

OrbiMed investment in Venture Round - Nucleix

oci-bio-investments_image

OCI Bio Investments

OCI Bio Investments investment in Venture Round - Nucleix

blackrock_image

BlackRock

BlackRock investment in Venture Round - Nucleix

dsc-investment_image

DSC Investment

DSC Investment investment in Venture Round - Nucleix

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Venture Round - Nucleix

orbimed-advisors_image

OrbiMed

OrbiMed investment in Venture Round - Nucleix

milfam_image

MILFAM

MILFAM investment in Venture Round - Nucleix

Official Site Inspections

http://www.nucleix.com Semrush global rank: 9.84 M Semrush visits lastest month: 95

  • Host name: 172.66.43.63
  • IP address: 172.66.43.63
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Nucleix"

Nucleix – Company

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based …See details»

Nucleix – About Us

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach …See details»

Nucleix

Nucleix R&D has the capabilities and experience to develop additional liquid biopsy assays for other types of cancerSee details»

Nucleix - Crunchbase Company Profile & Funding

Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation …See details»

Nucleix Company Profile 2024: Valuation, Funding & Investors

Developer of non-invasive molecular diagnostic tests designed to facilitate and ensure accurate and effective cancer detection. The company leverages DNA methylation patterns to detect …See details»

Nucleix - Org Chart, Teams, Culture & Jobs - The Org

Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic biomarkers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products …See details»

Nucleix Ltd. - VentureRadar

"Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging …See details»

Nucleix Receives CAP Accreditation and CLIA ... - Business Wire

Oct 19, 2022 · SAN DIEGO & REHOVOT, Israel-- (BUSINESS WIRE)--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced …See details»

Nucleix Company Profile - Office Locations, Competitors ... - Craft

Nucleix is a company that develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. They are based on the identification of subtle changes in methylation …See details»

Nucleix Announces Recent Advancements in Early Lung …

Jan 5, 2022 · SAN DIEGO & REHOVOT, Israel-- ( BUSINESS WIRE )--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, announced recent advances in its EpiCheck ®...See details»

Nucleix Raises $77 Million for New Lung Cancer Detection Tech

Jan 6, 2022 · Nucleix, an Israeli medtech startup that offers a liquid biopsy which it says can detect cancer early, secured an additional $22 million in funding, as an extension to the …See details»

Nucleix Secures $55 Million Funding Led by RA Capital …

Apr 7, 2021 · SAN DIEGO & REHOVOT, Israel-- ( BUSINESS WIRE )-- Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, has secured $55 …See details»

Nucleix - Overview, News & Similar companies | ZoomInfo.com

Apr 4, 2024 · View Nucleix (www.nucleix.com) location in Israel , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

Nucleix Raises Additional $22M - Precision Medicine Online

Jan 5, 2022 · Nucleix is developing liquid biopsy tests for early-stage and recurring cancer diagnosis that use PCR and next-generation sequencing technologies to detect tissue-specific …See details»

Liquid biopsy maker Nucleix rakes in $55M to develop blood tests …

Apr 8, 2021 · It’s full steam ahead for Nucleix’s blood test for lung cancer detection, thanks to an influx of cash in the Israeli company’s latest round of funding. The liquid biopsy maker closed its...See details»

☑️Nucleix — Consulting Organization,Supplier from Israel, …

Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic bio markers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products …See details»

Nucleix – United States

Bladder EpiCheck ®, CE-marked and available in Europe for primary and recurrent bladder cancer and upper tract urinary cancer, and FDA 510 (k) cleared for bladder cancer recurrence …See details»

Nucleix – Technology

Leveraging PCR-based epigenetics, our pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. Our platform delivers highly …See details»

Nucleix – News&Events

Jun 11, 2023 · A. Menarini Diagnostics and Nucleix Announce a Strategic Partnership for a Non-Invasive Bladder Cancer Test in EuropeSee details»

linkstock.net © 2022. All rights reserved